Alopecia Market To Reach USD 12.99 Billion By 2026www.reportsanddata.com

Market SummaryRising incidences of chronic disorders such as hyperthyroidism, acute stress disorder hypopituitarism, hypothyroidism, and lupus are the major factors influencing market growth.

Market Size – USD 8.64 billion in 2018, Market Growth - CAGR of 5.1%, Market Trends –Increase in disposable income coupled with rising concern about aesthetic appearance

The Alopecia Market is expected to reach USD 12.99 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with rising predominance of chronic disorders such as hyperthyroidism, hypothyroidism, acute stress disorder, lupus, and hypo pituitarism. Moreover, increasing incidence of Hodgkin’s disease, Hashimoto’s disease, Addison’s disease, and celiac disease along with factors such as access to quick treatment are expected to drive the market growth. However, high cost of treatment and adverse side effects is expected to restrain the growth. Also, changing lifestyle such as consumption of tobacco, an increase in the use of alcohol, and other associated products, growing stress levels, and the expanding population are expected to spur the market. Increasing disposable incomes coupled with the expanding emphasis on aesthetic appearance are also likely to add to the demand for alopecia treatment worldwide.

www.repo

rtsan

ddata.com

Market SummaryThe rising number of introduction of new drugs, consumer disposable incomes, and the complementary initiatives taken by the relevant organizations namely, AHLA and NAAF, are the crucial factors for the North America region to account for the largest market share of 22.30% in 2018.

Hair loss, also acknowledged as alopecia or baldness refers to a loss of hair from part of the head. The typical pattern of hair loss can vary from a small area to the entire body. Scarring or inflammation is not present. Hair loss in some people may cause psychological distress. General types include female-pattern hair loss, male-pattern hair loss, alopecia areata, and a thinning of hair also known as telogen effluvium. The cause of male-pattern hair loss is a combination of male hormones and genetics, the purpose of female pattern hair loss is not clear, the use of alopecia areata is auto-immune, and the cause of telogen effluvium is mostly a psychologically or physically stressful event.

Avail the inside scoop of the Sample report @ https://www.reportsanddata.com/sample-enquiry-form/1334

www.repo

rtsan

ddata.com

Market SummaryFurther key findings from the report suggest• Alopecia areata is an autoimmune skin disease identified by the hair loss on the scalp, face, and other

areas of the body. Alopecia areata is segmented into totalis, patchy, and universalis further.• Increasing predominance coupled with rising awareness regarding aesthetic appeal and physical

appearance is also assumed to drive the growth in the next few years.• Androgenetic type accounts for the largest market share of 42.20% in 2018 and is estimated to reach USD

5.51 billion by 2026.• Also, the availability of treatments such as oral treatments, licensed topical treatments involving the use of

finasteride and minoxidil; and surgical procedures such as hair replacement and transplantation are expected to drive the market.

Click here to avail the report at discount rate: https://www.reportsanddata.com/discount-enquiry-form/1334

www.repo

rtsan

ddata.com

Market SummaryKey participants include Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cirrus Hair Centers, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

For the purpose of this study, Reports and Data have segmented the global Alopecia Market on the basis of Disease, Gender, application, Sales distribution and region:Disease Outlook (Revenue, USD Million; 2016-2026)• Alopecia Areata• Androgenetic Alopecia• Others

Sales distribution Outlook (Revenue, USD Million; 2016-2026)• Prescriptions• OTC

To read the full report now, with industry-wide coverage, visit: https://www.reportsanddata.com/checkout-form/1334

www.repo

rtsan

ddata.com

Market SummaryApplication Outlook (Revenue, USD Million; 2016-2026)• Homecare Settings• Dermatology ClinicsGender Outlook (Revenue, USD Million; 2016-2026)• Female• MaleRegional Outlook (Revenue, USD Million; 2016-2026)• North America• Europe• Asia Pacific• Middle East & Africa• Latin America

www.repo

rtsan

ddata.com

About UsReports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision.

We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

John WatsonHead of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370E-mail: sales@reportsanddata.com

Contact US

www.repo

rtsan

ddata.com